SCHEMBL9145294

SCHEMBL9145294

OCCCCc1ccc2c(c1)CCc1ccccc1-2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.45
SRD5A2 P31213 1/20 0.45
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
BCHE P06276 4/20 0.41
GPR84 Q9NQS5 1/20 0.39
MITF O75030 1/20 0.39
HSP90AA1 P07900 1/20 0.39
ACHE P22303 2/20 0.38
IGF1R P08069 1/20 0.38
ALOX15 P16050 1/20 0.38
GPR3 P46089 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
GRIN2B Q13224 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PDK2 Q15119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8458964 0.88 SRD5A1 (0.49) SRD5A1SRD5A2RAB9ANPC1GPR84
SCHEMBL2311686 0.87 GPR84 (0.51) SRD5A2RAB9ANPC1BCHEGPR84
SCHEMBL783558 0.84 AKR1B1 (0.49) BCHEHSP90AA1ACHEIGF1RALOX15
SCHEMBL16064651 0.81 SRD5A1 (0.51) SRD5A1SRD5A2RAB9ANPC1GPR84
SCHEMBL503763 0.80 CYP1A2 (0.55) SRD5A1SRD5A2RAB9ANPC1MITF
SCHEMBL22369581 0.79 GRIN2B (0.44) BCHEACHEIGF1RALOX15CYP4F2
SCHEMBL3453711 0.78 SRD5A1 (0.45) SRD5A1SRD5A2RAB9ANPC1GPR84
SCHEMBL5684329 0.78 SRD5A1 (0.45) SRD5A1SRD5A2RAB9ANPC1GPR84
SCHEMBL11701595 0.76 AKR1B1 (0.51) SRD5A1SRD5A2CES1
SCHEMBL3531737 0.75 GAA (0.45) RAB9ANPC1BCHEGPR84ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5428065-A Treating central nervous system disorders LILLY INDUSTRIES LIMITED (GB) 1995-06-27 US disclosed
EP-0645370-A1 Substituted m-xylylene diamines for the treatment of diseases of the central nervous system LILLY INDUSTRIES LIMITED (GB) 1995-03-29 EP disclosed